It will now be important to use animal models to explore how attenuation of transcription of specific TGF-β/Activin target genes leads to the manifestations of SGS, and to understand why SGS patients exhibit additional defects compared with LDS and MFS patients. This evidence concerns the gene TGFB1 and Shprintzen-Goldberg syndrome.